Eli Lilly has announced an investment in Absci, a startup that is working on a medication aimed at promoting hair growth.
This move marks a strategic expansion for Eli Lilly into the hair loss treatment market, which has seen increasing interest.
Additionally, there are indications that the research may also have applications for treating endometriosis, though details remain unclear.
Updates
Update at 20:01 UTC on 2026-06-24
STAT reported Eli Lilly is investing in a small startup developing a medication to spur hair growth, and potentially also treat endometriosis.
Sources: STAT